Janus Henderson Group PLC Intellia Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 37,382 shares of NTLA stock, worth $817,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,382

Previous 37,841 1.21%

Holding current value

$817,918

Previous $1.04 Million 19.69%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $9,189 - $12,493	-459 Reduced 1.21%	37,382 $836,000
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $142 - $196	6 Added 0.02%	37,841 $1.04 Million
Q4 2023 Feb 14, 2024	SELL	$23.16 - $32.34 $880 - $1,228	-38 Reduced 0.1%	37,835 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $63 - $91	2 Added 0.01%	37,873 $1.2 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $227,259 - $302,509	6,572 Added 21.0%	37,871 $1.54 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $760,771 - $1.02 Million	-22,846 Reduced 42.19%	31,299 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $1.39 Million - $2.62 Million	41,714 Added 335.56%	54,145 $1.89 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $323 - $430	-6 Reduced 0.05%	12,431 $696,000
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $654 - $1,295	17 Added 0.14%	12,437 $644,000
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $15.1 Million - $30.8 Million	-258,581 Reduced 95.42%	12,420 $902,000
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $687,787 - $944,445	-6,826 Reduced 2.46%	271,001 $32 Million
Q3 2021 Nov 16, 2021	BUY	$132.37 - $176.78 $3.27 Million - $4.37 Million	24,730 Added 9.77%	277,827 $37.3 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $13.2 Million - $35.2 Million	217,437 Added 609.75%	253,097 $41 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $1.66 Million - $2.98 Million	35,660 New	35,660 $2.86 Million

Others Institutions Holding NTLA

# of Institutions

326

Shares Held

88.8M

Call Options Held

673K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.66B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Intellia Therapeutics, Inc. Transaction History